CSAM Health Group AS

OTCGREY:CSAMF USA Health Information Services
Market Cap
$98.80 Million
Market Cap Rank
#22203 Global
#7877 in USA
Share Price
$4.82
Change (1 day)
+0.00%
52-Week Range
$4.82 - $4.82
All Time High
$4.82
About

Omda AS provides software solutions for healthcare sector in Norway, Sweden, Denmark, and internationally. The company offers laboratory information management systems consist of CSAM ProSang, a blood, cell, and tissue management system; and medical medication solution comprising CSAM Cytodose, an oncology treatment management solution. It also provides connected healthcare solutions, including O… Read more

CSAM Health Group AS (CSAMF) - Net Assets

Latest net assets as of March 2025: $32.64 Million USD

Based on the latest financial reports, CSAM Health Group AS (CSAMF) has net assets worth $32.64 Million USD as of March 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($771.01 Million) and total liabilities ($738.37 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $32.64 Million
% of Total Assets 4.23%
Annual Growth Rate -13.84%
5-Year Change -90.06%
10-Year Change N/A
Growth Volatility 256.87

CSAM Health Group AS - Net Assets Trend (2018–2024)

This chart illustrates how CSAM Health Group AS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for CSAM Health Group AS (2018–2024)

The table below shows the annual net assets of CSAM Health Group AS from 2018 to 2024.

Year Net Assets Change
2024-12-31 $24.68 Million -74.09%
2023-12-31 $95.26 Million +231.06%
2022-12-31 $28.77 Million -82.73%
2021-12-31 $166.60 Million -32.92%
2020-12-31 $248.35 Million +626.22%
2019-12-31 $34.20 Million -43.32%
2018-12-31 $60.33 Million --

Equity Component Analysis

This analysis shows how different components contribute to CSAM Health Group AS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 8318000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Other Components $24.68 Million 100.00%
Total Equity $24.68 Million 100.00%

CSAM Health Group AS Competitors by Market Cap

The table below lists competitors of CSAM Health Group AS ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in CSAM Health Group AS's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 95,257,000 to 24,677,000, a change of -70,580,000 (-74.1%).
  • Net loss of 66,727,000 reduced equity.
  • Dividend payments of 9,741,000 reduced retained earnings.
  • Other factors increased equity by 5,888,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-66.73 Million -270.4%
Dividends Paid $9.74 Million -39.47%
Other Changes $5.89 Million +23.86%
Total Change $- -74.09%

Book Value vs Market Value Analysis

This analysis compares CSAM Health Group AS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.94x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 1.67x to 3.94x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2018-12-31 $2.89 $4.82 x
2019-12-31 $1.64 $4.82 x
2020-12-31 $11.88 $4.82 x
2021-12-31 $7.95 $4.82 x
2022-12-31 $1.37 $4.82 x
2023-12-31 $4.66 $4.82 x
2024-12-31 $1.22 $4.82 x

Capital Efficiency Dashboard

This dashboard shows how efficiently CSAM Health Group AS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -270.40%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -15.70%
  • • Asset Turnover: 0.54x
  • • Equity Multiplier: 31.92x
  • Recent ROE (-270.40%) is below the historical average (-114.35%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2018 -19.03% -6.86% 0.57x 4.84x $-17.51 Million
2019 -105.97% -17.64% 0.59x 10.12x $-39.66 Million
2020 -3.71% -4.03% 0.35x 2.66x $-34.06 Million
2021 -53.49% -27.06% 0.40x 4.89x $-105.78 Million
2022 -457.37% -35.89% 0.53x 24.10x $-134.48 Million
2023 109.55% 25.42% 0.53x 8.08x $94.82 Million
2024 -270.40% -15.70% 0.54x 31.92x $-69.19 Million

Industry Comparison

This section compares CSAM Health Group AS's net assets metrics with peer companies in the Health Information Services industry.

Industry Context

  • Industry: Health Information Services
  • Average net assets among peers: $79,108,599
  • Average return on equity (ROE) among peers: -247.59%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
CSAM Health Group AS (CSAMF) $32.64 Million -19.03% 22.62x $40.75 Million
Accolade, Inc. (ACCD) $473.79 Million -97.02% 0.91x $448.32 Million
Achiko AG (ACHKF) $-4.58 Million 0.00% 0.00x $314.42K
Ascom Holding AG (ACMLF) $78.70 Million 22.11% 1.51x $152.13 Million
Accelera Innovations Inc (ACNV) $-462.52K 0.00% 0.00x $5.72K
Aclarion Inc (ACON) $-7.08 Million 0.00% 0.00x $1.89 Million
Alternate Health Corp (AHGIF) $1.07 Million -2231.82% 7.94x $6.50K
AI/ML Innovations Inc (AIMLF) $2.09 Million -130.52% 0.72x $6.84 Million
NetraMark Holdings Inc. (AINMF) $-198.56K 0.00% 0.00x $70.13 Million
AMJ Global Technology (AMJT) $-21.78K 0.00% 0.00x $10.99 Million
American Well Corp (AMWL) $247.79 Million -38.62% 0.31x $78.62 Million